Research Analysts Set Expectations for SBC FY2024 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Equities researchers at Sidoti Csr cut their FY2024 earnings per share (EPS) estimates for shares of SBC Medical Group in a report issued on Wednesday, March 26th. Sidoti Csr analyst A. Shah now expects that the company will earn $0.57 per share for the year, down from their prior forecast of $0.58. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group’s Q1 2025 earnings at $0.16 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.64 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.18 EPS, Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.19 EPS and FY2026 earnings at $0.71 EPS.

SBC Medical Group Price Performance

SBC stock opened at $3.81 on Thursday. The firm’s 50 day moving average price is $4.48. SBC Medical Group has a 12-month low of $2.62 and a 12-month high of $12.50. The company has a current ratio of 2.79, a quick ratio of 2.76 and a debt-to-equity ratio of 0.06.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.